Huminig, Ayisha .
HRN: 27-31-84 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/27/2025
CEFUROXIME 250MG/5ML, 50ML SUSPENSION (BOT)
11/27/2025
12/02/2025
ORAL
3.5ml
BID
URTI
Checking Final Appropriateness
Indication: Empiric Type of Infection: URTI Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes